Skip to main content

Table 1 Demographic and clinical characteristics

From: Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings

Demographic or clinical item Enrolled population (EP)
Group A (PD 1st) Group B (BYOD 1st) Total
N = 23 N = 41 N = 64
Mean age (SD) 57.5 (11.33) 59.8 (10.13) 59.0 (10.55)
 Min–Max 40–75 40–77 40–77
Gender    
 Female 14 (60.9%) 28 (68.3%) 42 (65.6%)
 Male 9 (39.1%) 13 (31.7%) 22 (34.4%)
Race    
 White 13 (56.5%) 13 (31.7%) 26 (40.6%)
 Black/African American 6 (26.1%) 27 (65.9%) 33 (51.6%)
 Other 4 (17.4%) 1 (2.4%) 5 (7.8%)
Ethnicity    
 Hispanic/Latino 4 (17.4%) 1 (2.4%) 5 (7.8%)
 Not Hispanic/Latino 18 (78.3%) 40 (97.6%) 58 (90.6%)
 Do not wish to state 1 (4.8%) 0 1 (1.7%)
Education    
 Did Not complete high school 0 5 (12.2%) 5 (7.8%)
 High school diploma 8 (34.8%) 12 (29.3%) 20 (31.3%)
 Some college or certificate program 6 (26.1%) 13 (31.7%) 19 (29.7%)
 College or university degree 9 (39.1%) 8 (19.5%) 17 (26.6%)
 Graduate degree 0 3 (7.3%) 3 (4.7%)
Work status    
 Employed full-time 15 (65.2%) 11 (26.8%) 26 (40.6%)
 Employed part-time 2 (8.7%) 4 (9.8%) 6 (9.4%)
 Homemaker 1 (4.3%) 1 (2.4%) 2 (3.1%)
 Retired 2 (8.7%) 12 (29.3%) 14 (21.9%)
 Unemployed 0 3 (7.3%) 3 (4.7%)
 Disabled/on disability 3 (13.0%) 9 (22.0%) 12 (18.8%)
 Other 0 1 (2.4%) 1 (1.6%)
Gold Stage*    
 II 16 (69.6%) 30 (73.2%) 46 (71.9%)
 III 6 (26.1%) 10 (24.4%) 16 (25.0%)
 IV 1 (4.3%) 1 (2.4%) 2 (3.1%)
Participant-reported overall health    
 Very good 3 (13.0%) 8 (19.5%) 11 (17.2%)
 Good 16 (69.6%) 17 (41.5%) 33 (51.6%)
 Fair 3 (13.0%) 15 (36.6%) 18 (28.1%)
 Poor 1 (4.3%) 1 (2.4%) 2 (3.1%)
Clinician-reported COPD severity    
 Very mild 0 1 (2.4%) 1 (1.6%)
 Mild 0 13 (31.7%) 13 (20.3%)
 Moderate 18 (78.3%) 18 (43.9%) 36 (56.3%)
 Severe 5 (21.7%) 8 (19.5%) 13 (20.3%)
 Very severe 0 1 (2.4%) 1 (1.6%)
  1. BYOD Bring your own device, PD provisioned device, COPD chronic obstructive pulmonary disease
  2. *GOLD stage II = FEV1 value is between 50 and 79% normal, GOLD stage III = FEV1 value is between 30 and 49% normal, GOLD stage IV = FEV1 value is < 3% normal